Compare Cipta Selera Murni Tbk. (CSMI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Selera Murni Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cipta Selera Murni Tbk. trades at Rp126 (market cap 97.11B, 107.85M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Cipta Selera Murni Tbk. is more actively traded (107.85M versus 62.5K). Which is the better fit depends on your goals.
| CSMI | OBAT | |
|---|---|---|
Market Cap | 97.11B | 164.65B |
Volume | 107.85M | 62.5K |
Lot | 1.08M | 625 |
Turnover | 14.15B | 15.03M |
Average Price | 131.21 | 240.55 |
Value | 14.15B | 15.03M |
Indicative Equilibrium Price | 126 | 238 |
Indicative Equilibrium Volume | 7.55K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Selera Murni Tbk.
PT Cipta Selera Murni Tbk (Company) was established based on Notarial Deed No. 167 dated July 25,1983 of Winanto Wiryomartani, S.H., in Jakarta.
Read more on CSMI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
